The novel drug SHR-A1921 was safe and efficacious in patients with platinum-resistant ovarian cancer, according to phase 1 data.

An ad-hoc analysis found a higher rate of severe and life-threatening infections in patients with RET-mutant lung cancer ...

A nurse practitioner discusses how breast cancer treatment can impact sexual health, and how nurses and APPs can guide ...

With newer breast cancer treatments, it’s essential that nurses and APPs educate themselves and advocate for their patients.

October 2024 brought 4 new FDA drug approvals in the oncology space. With new drug regimens in both the solid tumor and blood ...

You can control where you focus your attention,” said Anne M. Reb, PhD, NP, who recently presented on a nurse-led ...

Research is analyzing the effect of imtermittent fasting on quality of life outcomes in patients undergoing radiation therapy ...

An expert discussed fam-trastuzumab deruxtecan-nxki for HER2-mutant and -overexpressing non-small cell lung cancer.

A nurse practitioner discusses ASCO’s recommendations of CDK4/6 inhibitors—namely abemaciclib and ribociclib—in certain ...

Advanced practice providers discuss the second-line use of elacestrant in patients with co-mutated, ER+, HER2—advanced or ...

Pharmacologic strategies may be able to prevent abnormal uterine bleeding in patients undergoing stem cell transplant.

While pregnancy-associated cancer risks increased with age, breast cancer during pregnancy tended to not impact obstetric ...